Tapewire

Nasdaq · USD

QTTB

Q32 Bio Inc.

Export transactions ↓
Tapewire entity
5594
SEC CIK
0001661998
Parsed reports
295

Last 12 months

Inside the activity.

4 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202600
Feb 202603
Mar 202600
Apr 202600
May 202640
Jun 202600
Jul 202600
Aug 202603
Sep 202600
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 24, 2022 Filed Feb 28, 2022 21:05 UTC
Kelly Timothy PChief Operating Officer
GrantRestricted Stock Units · Derivative 4,800 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-008062 · doc4.xml · derivative · entry 2

Kelly Timothy P · CIK 0001754067 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,800

Underlying: Common Stock · 4,800 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025.

F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

Read SEC document
February 24, 2022 Filed Feb 28, 2022 21:05 UTC
Kelly Timothy PChief Operating Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 28,200 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0000899243-22-008062 · doc4.xml · derivative · entry 1

Kelly Timothy P · CIK 0001754067 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,200

Underlying: Common Stock · 28,200 shares

Expires 2032-02-24

F1 · derivative.exercise_date: The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022.

Read SEC document
February 24, 2022 Filed Feb 28, 2022 21:05 UTC
Seymour AlbertChief Scientific Officer
GrantRestricted Stock Units · Derivative 21,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-008060 · doc4.xml · derivative · entry 2

Seymour Albert · CIK 0001735324 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 21,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025.

F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.

Read SEC document
February 24, 2022 Filed Feb 28, 2022 21:05 UTC
Seymour AlbertChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 128,000 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0000899243-22-008060 · doc4.xml · derivative · entry 1

Seymour Albert · CIK 0001735324 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,000

Underlying: Common Stock · 128,000 shares

Expires 2032-02-24

F1 · derivative.exercise_date: The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022.

Read SEC document
January 05, 2022 Filed Jan 12, 2022 21:05 UTC
Smith W BradfordCFO & Treasurer
SaleCommon Stock 2,182 $3.78 $8,248.40
Disclosure

SEC source: 0000899243-22-001749 · doc4.xml · nonDerivative · entry 2

Smith W Bradford · CIK 0001317678 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,418

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.80. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.

Read SEC document
January 05, 2022 Filed Jan 12, 2022 21:05 UTC
TZIANABOS ARTHURDirector · President & CEO
SaleCommon Stock 5,354 $3.78 $20,239.19
Disclosure

SEC source: 0000899243-22-001743 · doc4.xml · nonDerivative · entry 2

TZIANABOS ARTHUR · CIK 0001586226 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,011

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.80. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.

Read SEC document
January 05, 2022 Filed Jan 12, 2022 21:05 UTC
Kelly Timothy PChief Operating Officer
SaleCommon Stock 1,406 $3.78 $5,314.82
Disclosure

SEC source: 0000899243-22-001747 · doc4.xml · nonDerivative · entry 2

Kelly Timothy P · CIK 0001754067 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,224

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.79. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.

Read SEC document
January 05, 2022 Filed Jan 12, 2022 21:05 UTC
Seymour AlbertChief Scientific Officer
SaleCommon Stock 1,661 $3.78 $6,278.75
Disclosure

SEC source: 0000899243-22-001746 · doc4.xml · nonDerivative · entry 2

Seymour Albert · CIK 0001735324 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,646

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.79. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.

Read SEC document
January 05, 2022 Filed Jan 12, 2022 21:05 UTC
Cohn GabrielChief Medical Officer
SaleCommon Stock 1,661 $3.78 $6,278.75
Disclosure

SEC source: 0000899243-22-001745 · doc4.xml · nonDerivative · entry 2

Cohn Gabriel · CIK 0001794702 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,629

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.

F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.79. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:05 UTC
Smith W BradfordCFO & Treasurer
Exercise / conversionRestricted Stock Units · Derivative 6,600 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-001749 · doc4.xml · derivative · entry 3

Smith W Bradford · CIK 0001317678 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,400

Underlying: Common Stock · 6,600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.

F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:05 UTC
Smith W BradfordCFO & Treasurer
Exercise / conversionCommon Stock 6,600 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-001749 · doc4.xml · nonDerivative · entry 1

Smith W Bradford · CIK 0001317678 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:05 UTC
TZIANABOS ARTHURDirector · President & CEO
Exercise / conversionRestricted Stock Units · Derivative 13,860 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-001743 · doc4.xml · derivative · entry 3

TZIANABOS ARTHUR · CIK 0001586226 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,140

Underlying: Common Stock · 13,860 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.

F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:05 UTC
TZIANABOS ARTHURDirector · President & CEO
Exercise / conversionCommon Stock 13,860 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-001743 · doc4.xml · nonDerivative · entry 1

TZIANABOS ARTHUR · CIK 0001586226 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,365

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:05 UTC
Kelly Timothy PChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 3,630 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-001747 · doc4.xml · derivative · entry 3

Kelly Timothy P · CIK 0001754067 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,370

Underlying: Common Stock · 3,630 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.

F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:05 UTC
Kelly Timothy PChief Operating Officer
Exercise / conversionCommon Stock 3,630 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-001747 · doc4.xml · nonDerivative · entry 1

Kelly Timothy P · CIK 0001754067 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,630

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:05 UTC
Seymour AlbertChief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 4,290 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-001746 · doc4.xml · derivative · entry 3

Seymour Albert · CIK 0001735324 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,710

Underlying: Common Stock · 4,290 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.

F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:05 UTC
Seymour AlbertChief Scientific Officer
Exercise / conversionCommon Stock 4,290 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-001746 · doc4.xml · nonDerivative · entry 1

Seymour Albert · CIK 0001735324 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:05 UTC
Cohn GabrielChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 4,290 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-001745 · doc4.xml · derivative · entry 3

Cohn Gabriel · CIK 0001794702 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,710

Underlying: Common Stock · 4,290 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.

F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.

Read SEC document
January 01, 2022 Filed Jan 12, 2022 21:05 UTC
Cohn GabrielChief Medical Officer
Exercise / conversionCommon Stock 4,290 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-001745 · doc4.xml · nonDerivative · entry 1

Cohn Gabriel · CIK 0001794702 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,290

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Read SEC document
September 03, 2021 Filed Sep 8, 2021 20:10 UTC
Kelly Timothy PSee Remarks.
SaleCommon Stock 54 $7.70 $415.80
Disclosure

SEC source: 0000899243-21-035330 · doc4.xml · nonDerivative · entry 1

Kelly Timothy P · CIK 0001754067 · See Remarks.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.

F2 · shares: Includes 54 shares acquired under Issuer's Employee Stock Purchase Plan on August 31, 2021.

Read SEC document
June 17, 2021 Filed Jun 22, 2021 21:39 UTC GrantOption (Right to Buy) · Derivative 18,000 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0000899243-21-025330 · doc4.xml · derivative · entry 1

Poulton Jeffrey V. · CIK 0001782962 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document
June 17, 2021 Filed Jun 22, 2021 17:40 UTC GrantOption (Right to Buy) · Derivative 18,000 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0000899243-21-025333 · doc4.xml · derivative · entry 1

Patterson Matthew R · CIK 0001401018 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document
June 17, 2021 Filed Jun 22, 2021 21:35 UTC GrantOption (Right to Buy) · Derivative 18,000 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0000899243-21-025321 · doc4.xml · derivative · entry 1

GILLIS STEVEN · CIK 0001229592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document
June 17, 2021 Filed Jun 22, 2021 21:35 UTC
Thistle MaryDirector
GrantOption (Right to Buy) · Derivative 18,000 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0000899243-21-025322 · doc4.xml · derivative · entry 1

Thistle Mary · CIK 0001317917 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document
June 17, 2021 Filed Jun 22, 2021 17:41 UTC GrantOption (Right to Buy) · Derivative 18,000 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0000899243-21-025335 · doc4.xml · derivative · entry 1

Gregory Richard J. · CIK 0001629767 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document
June 17, 2021 Filed Jun 22, 2021 21:40 UTC
PARMAR KUSHDirector
GrantOption (Right to Buy) · Derivative 18,000 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0000899243-21-025334 · doc4.xml · derivative · entry 1

PARMAR KUSH · CIK 0001664281 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document
June 17, 2021 Filed Jun 22, 2021 21:40 UTC
REICIN ALISEDirector
GrantOption (Right to Buy) · Derivative 18,000 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0000899243-21-025331 · doc4.xml · derivative · entry 1

REICIN ALISE · CIK 0001757533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-06-17

F1 · derivative.exercise_date: This option shall vest and become exercisable on the earlier of June 17, 2022 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.

Read SEC document
April 07, 2021 Filed Apr 10, 2021 01:30 UTC
Kelly Timothy PChief Operating Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.18 $0.00
Disclosure

SEC source: 0000899243-21-015515 · doc4.xml · derivative · entry 1

Kelly Timothy P · CIK 0001754067 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-04-07

F1 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after April 12, 2021, so that such option will become fully vested on April 12, 2025.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 21:05 UTC
Kelly Timothy PSee Remarks.
Exercise / conversionEmployee Stock Options · Derivative 2,000 $0.00 Strike: $2.89 $0.00
Disclosure

SEC source: 0000899243-21-009370 · doc4.xml · derivative · entry 5

Kelly Timothy P · CIK 0001754067 · See Remarks.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,001

Underlying: Common Stock · 2,000 shares

Expires 2027-09-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was May 30, 2017.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 21:05 UTC
Kelly Timothy PSee Remarks.
Exercise / conversionEmployee Stock Options · Derivative 2,000 $0.00 Strike: $6.63 $0.00
Disclosure

SEC source: 0000899243-21-009370 · doc4.xml · derivative · entry 4

Kelly Timothy P · CIK 0001754067 · See Remarks.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,500

Underlying: Common Stock · 2,000 shares

Expires 2027-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 21:05 UTC
Kelly Timothy PSee Remarks.
SaleCommon Stock 6,232 $11.16 $69,562.83
Disclosure

SEC source: 0000899243-21-009370 · doc4.xml · nonDerivative · entry 3

Kelly Timothy P · CIK 0001754067 · See Remarks.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.

F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $10.9600 to $11.3100. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 21:05 UTC
Kelly Timothy PSee Remarks.
Exercise / conversionCommon Stock 2,000 $2.89 $5,789.40
Disclosure

SEC source: 0000899243-21-009370 · doc4.xml · nonDerivative · entry 2

Kelly Timothy P · CIK 0001754067 · See Remarks.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2021 Filed Mar 3, 2021 21:05 UTC
Kelly Timothy PSee Remarks.
Exercise / conversionCommon Stock 2,000 $6.63 $13,262.80
Disclosure

SEC source: 0000899243-21-009370 · doc4.xml · nonDerivative · entry 1

Kelly Timothy P · CIK 0001754067 · See Remarks.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 2,232 shares acquired under Issuer's Employee Stock Purchase Plan on February 26, 2021.

Read SEC document
March 01, 2021 Filed Sep 8, 2021 20:05 UTC Amendment
Kelly Timothy PSee Remarks
SaleCommon Stock 6,232 $11.16 $69,562.83
Disclosure

SEC source: 0000899243-21-035329 · doc4a.xml · nonDerivative · entry 1

Kelly Timothy P · CIK 0001754067 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.

F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $10.9600 to $11.3100. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 08, 2021 Filed Feb 9, 2021 21:22 UTC
Smith W BradfordCFO & Treasurer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 13,500 $0.00 Strike: $0.64 $0.00
Disclosure

SEC source: 0000899243-21-005458 · doc4.xml · derivative · entry 5

Smith W Bradford · CIK 0001317678 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,904

Underlying: Common Stock · 13,500 shares

Expires 2027-04-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017.

Read SEC document
February 08, 2021 Filed Feb 9, 2021 21:22 UTC
Smith W BradfordCFO & Treasurer
SaleCommon Stock 13,500 $14.25 $192,424.95
Disclosure

SEC source: 0000899243-21-005458 · doc4.xml · nonDerivative · entry 2

Smith W Bradford · CIK 0001317678 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2020.

F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $14.00 to $14.60. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 08, 2021 Filed Feb 9, 2021 21:22 UTC
Smith W BradfordCFO & Treasurer
Exercise / conversionCommon Stock 13,500 $0.64 $8,640.00
Disclosure

SEC source: 0000899243-21-005458 · doc4.xml · nonDerivative · entry 1

Smith W Bradford · CIK 0001317678 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 21:22 UTC
Smith W BradfordCFO & Treasurer
GrantRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-005458 · doc4.xml · derivative · entry 4

Smith W Bradford · CIK 0001317678 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F5 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

F5 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 21:22 UTC
Smith W BradfordCFO & Treasurer
GrantEmployee Stock Option (Right to Buy) · Derivative 122,000 $0.00 Strike: $13.78 $0.00
Disclosure

SEC source: 0000899243-21-005458 · doc4.xml · derivative · entry 3

Smith W Bradford · CIK 0001317678 · CFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,000

Underlying: Common Stock · 122,000 shares

Expires 2031-02-05

F3 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 21:21 UTC
TZIANABOS ARTHURDirector · President & CEO
GrantRestricted Stock Units · Derivative 42,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-005455 · doc4.xml · derivative · entry 2

TZIANABOS ARTHUR · CIK 0001586226 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 21:21 UTC
TZIANABOS ARTHURDirector · President & CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 254,000 $0.00 Strike: $13.78 $0.00
Disclosure

SEC source: 0000899243-21-005455 · doc4.xml · derivative · entry 1

TZIANABOS ARTHUR · CIK 0001586226 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,000

Underlying: Common Stock · 254,000 shares

Expires 2031-02-05

F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 21:25 UTC
Seymour AlbertChief Scientific Officer
GrantRestricted Stock Units · Derivative 13,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-005461 · doc4.xml · derivative · entry 2

Seymour Albert · CIK 0001735324 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 13,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 21:25 UTC
Seymour AlbertChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 78,000 $0.00 Strike: $13.78 $0.00
Disclosure

SEC source: 0000899243-21-005461 · doc4.xml · derivative · entry 1

Seymour Albert · CIK 0001735324 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,000

Underlying: Common Stock · 78,000 shares

Expires 2031-02-05

F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 21:22 UTC
Cohn GabrielChief Medical Officer
GrantRestricted Stock Units · Derivative 13,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-005456 · doc4.xml · derivative · entry 2

Cohn Gabriel · CIK 0001794702 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 13,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 21:22 UTC
Cohn GabrielChief Medical Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 78,000 $0.00 Strike: $13.78 $0.00
Disclosure

SEC source: 0000899243-21-005456 · doc4.xml · derivative · entry 1

Cohn Gabriel · CIK 0001794702 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,000

Underlying: Common Stock · 78,000 shares

Expires 2031-02-05

F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 21:24 UTC
Kelly Timothy PSee Remarks
GrantRestricted Stock Units · Derivative 11,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-005460 · doc4.xml · derivative · entry 2

Kelly Timothy P · CIK 0001754067 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

F3 · derivative.expiration_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.

Read SEC document
February 05, 2021 Filed Feb 9, 2021 21:24 UTC
Kelly Timothy PSee Remarks
GrantEmployee Stock Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $13.78 $0.00
Disclosure

SEC source: 0000899243-21-005460 · doc4.xml · derivative · entry 1

Kelly Timothy P · CIK 0001754067 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2031-02-05

F1 · derivative.exercise_date: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021.

Read SEC document
February 02, 2021 Filed Feb 5, 2021 11:31 UTC
Kelly Timothy PSee Remarks
Exercise / conversionEmployee Stock Options · Derivative 500 $0.00 Strike: $6.63 $0.00
Disclosure

SEC source: 0000899243-21-004998 · doc4.xml · derivative · entry 3

Kelly Timothy P · CIK 0001754067 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,500

Underlying: Common Stock · 500 shares

Expires 2027-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022.

Read SEC document
February 02, 2021 Filed Feb 5, 2021 11:31 UTC
Kelly Timothy PSee Remarks
SaleCommon Stock 500 $13.00 $6,500.00
Disclosure

SEC source: 0000899243-21-004998 · doc4.xml · nonDerivative · entry 2

Kelly Timothy P · CIK 0001754067 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.

Read SEC document
February 02, 2021 Filed Feb 5, 2021 11:31 UTC
Kelly Timothy PSee Remarks
Exercise / conversionCommon Stock 500 $6.63 $3,315.70
Disclosure

SEC source: 0000899243-21-004998 · doc4.xml · nonDerivative · entry 1

Kelly Timothy P · CIK 0001754067 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.